Table II.
Groups | N | Tumor-free survival (months) | Relapse rate, n (%) | Survival rate, n (%) |
---|---|---|---|---|
Control | 50 | 8.4 | 17 (34.0) | 35 (70.0) |
Treatment | 40 | 12.3 | 6 (15.0) | 35 (87.5) |
χ2 | 8.324 | 4.217 | 3.938 | |
P-value | 0.006 | 0.040 | 0.047 |
Groups | N | Tumor-free survival (months) | Relapse rate, n (%) | Survival rate, n (%) |
---|---|---|---|---|
Control | 50 | 8.4 | 17 (34.0) | 35 (70.0) |
Treatment | 40 | 12.3 | 6 (15.0) | 35 (87.5) |
χ2 | 8.324 | 4.217 | 3.938 | |
P-value | 0.006 | 0.040 | 0.047 |